8-K - IMMUNIC, INC. - 3.03 / 5.03 / 8.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193805-26-000495
Filing Date: 2026-04-23
Accepted: 2026-04-23 08:30:43
Documents: 14
Period of Report: 2026-04-22
Items: Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
IMMUNIC, INC. (Filer) CIK : 0001280776 (see all company filings) EIN. : 562358443 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 26885710 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | e665386_8k-immunic.htm iXBRL | 8-K | 25555
2 | e665386_ex3-1.htm | EX-3.1 | 5858
3 | e665386_ex99-1.htm | EX-99.1 | 14101
7 | GRAPHIC | image_001.jpg | GRAPHIC